These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 1356787)

  • 21. Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
    Schuldiner S; Steiner-Mordoch S; Yelin R; Wall SC; Rudnick G
    Mol Pharmacol; 1993 Dec; 44(6):1227-31. PubMed ID: 7903417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MDMA (ecstasy) inhibition of MAO type A and type B: comparisons with fenfluramine and fluoxetine (Prozac).
    Leonardi ET; Azmitia EC
    Neuropsychopharmacology; 1994 Jul; 10(4):231-8. PubMed ID: 7945733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-methyl-D-aspartate antagonist MK-801 protects against serotonin depletions induced by methamphetamine, 3,4-methylenedioxymethamphetamine and p-chloroamphetamine.
    Farfel GM; Vosmer GL; Seiden LS
    Brain Res; 1992 Nov; 595(1):121-7. PubMed ID: 1361410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurochemistry and neurotoxicity of substituted amphetamines.
    Wagner J; Peroutka SJ
    Neuropsychopharmacology; 1990 Jun; 3(3):219-20. PubMed ID: 1973040
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
    Colado MI; O'Shea E; Granados R; Murray TK; Green AR
    Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 29. A neuropharmacological analysis of the discriminative stimulus properties of fenfluramine.
    White FJ; Appel JB
    Psychopharmacology (Berl); 1981; 73(2):110-5. PubMed ID: 6785800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine-induced inhibition of synaptosomal [3H]5-HT release: possible Ca(2+)-channel inhibition.
    Stauderman KA; Gandhi VC; Jones DJ
    Life Sci; 1992; 50(26):2125-38. PubMed ID: 1608295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM; Gozlan H; Hamon M
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia.
    Quock RM; Weick BG
    J Pharm Pharmacol; 1979 Jan; 31(1):27-32. PubMed ID: 32362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD
    Neuroendocrinology; 1980 Aug; 31(2):96-100. PubMed ID: 6446690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amphetamine analogs increase plasma serotonin: implications for cardiac and pulmonary disease.
    Zolkowska D; Rothman RB; Baumann MH
    J Pharmacol Exp Ther; 2006 Aug; 318(2):604-10. PubMed ID: 16644904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro.
    Gobbi M; Moia M; Pirona L; Ceglia I; Reyes-Parada M; Scorza C; Mennini T
    J Neurochem; 2002 Sep; 82(6):1435-43. PubMed ID: 12354291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
    Xie T; Tong L; McLane MW; Hatzidimitriou G; Yuan J; McCann U; Ricaurte G
    Neuropsychopharmacology; 2006 Dec; 31(12):2639-51. PubMed ID: 16452989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism.
    Steranka LR; Sanders-Bush E
    J Pharmacol Exp Ther; 1978 Aug; 206(2):460-7. PubMed ID: 682126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of monoamine and corticosterone levels 24 h following (+)methamphetamine, (+/-)3,4-methylenedioxymethamphetamine, cocaine, (+)fenfluramine or (+/-)methylphenidate administration in the neonatal rat.
    Schaefer TL; Ehrman LA; Gudelsky GA; Vorhees CV; Williams MT
    J Neurochem; 2006 Sep; 98(5):1369-78. PubMed ID: 16923155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coincidence of blockade of synaptosomal 5-hydroxytryptamine uptake and decrease in tryptophan hydroxylase activity: effects of fenfluramine.
    Knapp S; Mandell AJ
    J Pharmacol Exp Ther; 1976 Jul; 198(1):123-32. PubMed ID: 933002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different action of 5-hydroxytryptamine (5-HT) uptake inhibitors on fenfluramine- but not p-chloramphetamine-induced hyperthermia in rats.
    Paełowski L
    J Pharm Pharmacol; 1981 Aug; 33(8):538-40. PubMed ID: 6115932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.